期刊文献+

gp100:209-217(210M)疫苗的研究进展 被引量:2

下载PDF
导出
摘要 黑色素瘤是恶性程度最高的皮肤肿瘤,具有高复发率和高死亡率的特点,其5年生存率低于10%,属于最难有效治疗的肿瘤之一。由于黑色素瘤易发生转移,主要治疗方法为及早局部手术切除根治、晚期化疗和放疗等,但结果均不理想。近年来,随着分子生物学及基因工程技术的发展,利用多肽疫苗治疗黑色素瘤的方法受到广泛关注。多肽疫苗通过启动人体自身的免疫功能对抗肿瘤细胞,不会破坏人体其他健康的生理组织,安全性高。
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第1期142-144,共3页 Chinese Journal of Immunology
基金 江苏高校优势学科建设工程资助
  • 相关文献

参考文献31

  • 1Zhao F,Dou J,He XF,et al.Enhancing therapy of melanoma efficacy via tumor cell vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model[J].Vaccine,2010,28(16):2486-2852.
  • 2He X,Wang J,Zhao F,et al.ESAT-6-gpi DNA vaccine augmentthe specific anti-tumor efficacy induced by the tumor vaccine B16F10-ESAT-6-gpi/IL-21 in mice[J].Scand J Immunol,2013,78(1):69-78.
  • 3BenlaIam H,Linard B,Guilloux Y,et al.Identification of five new HLA-B * 3501-restricted epitopes derived from common melan-oma-associated antigens,spontaneously recognized by tumor-infiltrating lymphocytes[J].J Immunol,2003,171(11):6283-62B9.
  • 4Hartmann TB,Bazhin AV,Schadendorf D,et al.SEREX identification of new tumor antigens linked to melanoma-associated retinopathy[J].Int J Cancer,2005,114(1):88-93.
  • 5李昂,刘荣军,林怡,熊思东,储以微.人黑色素肿瘤相关抗原gp100质粒诱导特异性抗小鼠黑色素瘤的免疫保护效应[J].中华微生物学和免疫学杂志,2006,26(4):334-338. 被引量:2
  • 6张正华,刘维达.黑素瘤疫苗的研究进展[J].国外医学(皮肤性病学分册),2003,29(4):253-256. 被引量:2
  • 7黄进(编译).gp100:209—217[J].中国处方药,2009(5):17-17. 被引量:1
  • 8Dudley ME,Ngo LT,Westwood J,et al.T-cell clones frommelanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes[J].Cancer J,2000,6(2):69-77.
  • 9Thomas FG,Hodi FS.Targeted therapeutics in Melanoma[M].New York:Springer,2012;207-232.
  • 10Linse KD.Category Archives:Genetics[DB/OL].http://blog-biosyn.com/category/genetics/,2013.

二级参考文献88

  • 1Powell DJ, Rosenberg SA. Phenotypic and Functional Mat- urationof Tumor Antigen Reactive CD8^+ T Lymphocytes in Patients Undergoing Multiple Course Peptide Vaccination [J]. J Immunother, 2004,27 (1) : 36.
  • 2Cormier JN, Salgaller ML, Prevette T, etal. Enhancement of Cellular Immunity in Melanoma Patients Immunized with a Peptide from MART-1/Melan A[J]. Cancer J Sci Am, 1997,3(1):37.
  • 3Chianese-Bullock KA, Pressley J, Garbee C,et al. MAGE-Al-, MAGE A10 , and gp100-Derived Peptides Are Immu- nogenic When Combined with Granuloeyte-Macrophage Col- ony-Stimulating Factor and Montanide ISA-51 Adjuvant and Administered as Part of a Multipeptide Vaccine for Melano- ma[J]. J Immunol, 2005,174:3080.
  • 4Ebert LM, Liu YC, Clements CS, etal. A long, naturally presented immunodorninant epitope from NY-ESO-1 tumor antigen., implications for cancer vaccine design[J]. Cancer Res, 2009,69(3) :1046.
  • 5Marchand M, Baren NV, Weynants P, et al. Tumor re- gressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-Al [J]. Int J Cancer, 1999, 80:219.
  • 6Jager E, Gnjatic S, Nagata Y, et al. Induction of primary NY-ESO-1 immunity: CDS1 T lymphocyte and antibody re sponses in peptide-vaeeinated patients with NY-ESO-11 cancers[J]. PNAS, 2000,97(22) : 12198.
  • 7Kirkwood JM, Lee S, Moschos SJ, et al. Immunogenicity and antitumor effects of vaccination with peptide vaccine +/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Co- operative Oneology Group Phase II Trial E1696[J]. Clin Cancer Res, 2009,15 (4) : 1443.
  • 8Rosenberg SA, Yang JC, Douglas J,et al. Impact of Cyto- kine Administration on Vaccine Melanoma Receiving a Pep tide Reactivity in Patients with Metastatic the Generation of Antitumor[J]. J Immunol , 1999,163:1690.
  • 9Sosrnan JA, Carrillo C, Urba WJ, et al. Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2 - Positive Advanced Melanoma [J]. J Clin Oncol, 2008, 26: 2292.
  • 10Smith FO, Downey SG, Klapper JA, et al. Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Con- junction with Vaccines[J]. Clin Cancer Res, 2008,14(17) : 5610.

共引文献13

同被引文献5

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部